Archives of Pharmacal Research

Papers
(The H4-Index of Archives of Pharmacal Research is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Recent paclitaxel formulation strategies: expanding the therapeutic index by addressing biopharmaceutical and toxicity limitations270
Mouse models of nonalcoholic steatohepatitis and their application to new drug development107
Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation88
Evaluation of bone health and fracture risk in type 2 diabetes: a network meta-analysis of anti-diabetic treatments versus placebo88
Osteogenic effect of an adiponectin-derived short peptide that rebalances bone remodeling: a potential disease-modifying approach for postmenopausal osteoporosis therapy80
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities66
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin63
Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration62
Correction to: The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer61
Impact of binge drinking on alcoholic liver disease58
Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis49
PBPK modeling of the antidepressant doxepin incorporating CYP2D6 genotype for precision pharmacotherapy45
Germacrane and humulane sesquiterpenes from the roots and rhizomes of Valeriana officinalis var. latifolia and their anti-inflammatory and anti-influenza virus activities45
Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway45
Retraction Note: Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats44
Regulation of NOX/p38 MAPK/PPARα pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight43
Prenylated flavonoid fractions from Glycyrrhiza glabra alleviate insulin resistance in HepG2 cells by regulating the ERK/IRS-1 and PI3K/Akt signaling pathways42
Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions42
Isolation, structure elucidation, total synthesis, and biosynthesis of dermazolium A, an antibacterial imidazolium metabolite of a vaginal bacterium Dermabacter vaginalis38
Minor structural changes, major functional impacts: posttranslational modifications and drug targets36
The role and application of transcriptional repressors in cancer treatment35
Recent advances on Pestalotiopsis genus: chemistry, biological activities, structure–activity relationship, and biosynthesis34
Non-alcoholic fatty liver disease and liver secretome33
A review on bacteria-derived antioxidant metabolites: their production, purification, characterization, potential applications, and limitations32
Naringin promotes fat browning mediated by UCP1 activation via the AMPK signaling pathway in 3T3-L1 adipocytes31
Tirzepatide mitigates atherosclerosis progression and modulates oxLDL-mediated proatherogenic effects in macrophages: evidence for M1/M2 homeostasis restoration31
Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes28
Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation27
Anti-osteoporosis effects of triterpenoids from the fruit of sea buckthorn (Hippophae rhamnoides) through the promotion of osteoblast differentiation in mesenchymal stem cells, C3H10T1/227
0.093180894851685